he central government will support Hyderabad based Indian Immunological limited (IIL) with grants under the Mission COVID Suraksha for developing…
Manufacturing to supply of Covid-19 vaccine Covaxin involves four months of lag time depending on technology and regulatory approvals, Bharat…
In the first of its kind study since the launch of the AstraZeneca's Covishield and Bharat Biotech's Covaxin in the…
The World Health Organisation (WHO) has said more information is required from Bharat Biotech, which is seeking emergency use listing…
Bharat Biotech, the maker of coronavirus disease vaccine Covaxin, is expected to start paediatric trials from June, the company's Business…
Few side effects of vaccination are common and that shouldn’t deter anyone from taking it said Dr. Raches Ella, Head-Business…
Bharat Biotech on Thursday said it has ramped up additional manufacturing capacities for the Covaxin covid-19 jabs as the country…
The Phase 2-3 clinical trials of Covid-19 vaccine, Covaxin, which has been approved by the Drugs Controller General of India (DCGI),…
With several states complaining of vaccine shortage, the Centre on Saturday stated that the plan is to ramp up the…
As Bharat Biotech's Covaxin will now be manufactured by two public sector undertakings, the Centre on Saturday said that private…